perfusion with PBS and 4% paraformaldehyde. Brains were removed, stored in 4%
paraformaldehyde at 4 °C overnight, and immersed in 30% sucrose for 3 to 4 d at 4 °C.
Brains were then frozen rapidly in powdered dry ice and stored at −70 °C. Frozen brains
were sectioned coronally between 3 and 4 mm posterior to the bregma to a thickness of 18
µm using a Cryocut Microtome (Leica Microsystems). The neurogenetic and angiogenetic
effects of hMSCs were measured by immunofluorescence staining as previously described10 (link). All rats received 5-bromo-2′-deoxyuridine (50 mg/kg, intraperitoneal, BrdU; Roche
Holding AG, Basel, Switzerland) injections per day for the last week. Neurogenesis and
angiogenesis effects were calculated using immunostaining with mouse anti-BrdU (diluted
1:50, Abcam, Cambridge, United Kingdom)/rabbit anti-doublecortin (anti-DCX, diluted 1:200,
Abcam) or rabbit anti–von Willebrand factor (anti-vWF, diluted 1:200, Chemicon, Temecula,
CA, USA). Images were acquired with an EVOS fl microscope (Advanced Microscopy Group). The
number of BrdU/DCX double-positive cells was measured with Image (National Institutes of
Health, Bethesda, MD, USA). The area of vWF was analyzed using Multi Gauge (Fuji Photo
Film Co. Ltd., Tokyo, Japan).